A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis

NCT00317356 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

43

Enrollment

INDUSTRY

Sponsor class

Stopped Efficacy was not cleared at US study

Conditions

Colitis, Ulcerative

Interventions

DRUG: OPC-6535(Tetomilast)

Sponsor

Otsuka Pharmaceutical Co., Ltd.